{"id":366650,"date":"2025-09-01T10:30:14","date_gmt":"2025-09-01T10:30:14","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-iradimed-corporation\/"},"modified":"2025-09-01T10:30:14","modified_gmt":"2025-09-01T10:30:14","slug":"how-to-buy-iradimed-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/","title":{"rendered":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-366650","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"IRADIMED CORPORATION (IRMD) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ve bu yenilik\u00e7i medikal cihaz \u015firketi i\u00e7in 2025-2030 b\u00fcy\u00fcme projeksiyonlar\u0131 dahil.","description_source":{"label":"Description","type":"textarea","formatted_value":"IRADIMED CORPORATION (IRMD) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ve bu yenilik\u00e7i medikal cihaz \u015firketi i\u00e7in 2025-2030 b\u00fcy\u00fcme projeksiyonlar\u0131 dahil."},"intro":"\u0130leri teknoloji medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? IRADIMED CORPORATION (IRMD), d\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 sistemleri tedarik\u00e7isi olarak hisse sahibi olma f\u0131rsat\u0131 sunuyor. Bu yenilik\u00e7i \u015firket, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki istikrar\u0131 teknolojik yenilikle birle\u015ftiriyor\u2014\u00f6zelle\u015fmi\u015f medikal cihazlarda b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine ve neden 2025'in ola\u011fan\u00fcst\u00fc f\u0131rsatlar sundu\u011funa kadar her \u015feyi ke\u015ffedece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri teknoloji medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? IRADIMED CORPORATION (IRMD), d\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 sistemleri tedarik\u00e7isi olarak hisse sahibi olma f\u0131rsat\u0131 sunuyor. Bu yenilik\u00e7i \u015firket, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki istikrar\u0131 teknolojik yenilikle birle\u015ftiriyor\u2014\u00f6zelle\u015fmi\u015f medikal cihazlarda b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine ve neden 2025'in ola\u011fan\u00fcst\u00fc f\u0131rsatlar sundu\u011funa kadar her \u015feyi ke\u015ffedece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 IRADIMED Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla IRADIMED CORPORATION (IRMD), NASDAQ'ta <strong>73,85 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu, 2025 boyunca s\u00fcrekli rekor k\u0131ran \u00e7eyreklik sonu\u00e7lar sunan bir \u015firket i\u00e7in g\u00fc\u00e7l\u00fc bir ivmeyi temsil ediyor.<\/p> <p>Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik bir tarih. IRADIMED'in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirerek yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsatlar hem de riskler yaratm\u0131\u015ft\u0131r.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 IRMD Hissesini Nas\u0131l Etkiler?<\/h3> <p>Son performans \u00f6r\u00fcnt\u00fclerine dayanarak, IRADIMED analist beklentilerini tutarl\u0131 \u015fekilde a\u015fm\u0131\u015ft\u0131r:<\/p> <ul> <li><strong>1 A\u011fustos 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: Tahminleri %13,95 a\u015farak 0,49 $ non-GAAP EPS bildirdi (<a href=\"https:\/\/public.com\/stocks\/irmd\/earnings\">Kazan\u00e7 Verileri<\/a>)<\/li> <li><strong>5 May\u0131s 2025 (1. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: Tahminleri %2,44 a\u015farak 0,42 $ non-GAAP EPS sundu<\/li> <li><strong>13 \u015eubat 2025 (2024 4. \u00c7eyrek)<\/strong>: Tam olarak beklentileri kar\u015f\u0131layarak 0,44 $ EPS<\/li> <li><strong>31 Ekim 2024 (2024 3. \u00c7eyrek)<\/strong>: Tahminleri %13,16 a\u015farak 0,43 $ EPS<\/li> <\/ul> <p>Desen a\u00e7\u0131k: IRADIMED beklentileri tutarl\u0131 \u015fekilde kar\u015f\u0131l\u0131yor veya a\u015f\u0131yor, son \u00e7eyreklerde \u00f6zellikle g\u00fc\u00e7l\u00fc bir performans sergiliyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>IRADIMED hisseleri son alt\u0131 ayda ola\u011fan\u00fcst\u00fc performans g\u00f6sterdi, May\u0131s'tan A\u011fustos 2025'e yakla\u015f\u0131k <strong>%40<\/strong> y\u00fckseldi:<\/p> <p><strong>Mart 2025<\/strong>: K\u0131\u015f konsolidasyonunun ard\u0131ndan 51-52 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<br\/> <strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u015fmas\u0131n\u0131n ard\u0131ndan 51,85 $ seviyesine ula\u015ft\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IRMD\/forecast\/\">Piyasa Analizi<\/a>)<br\/> <strong>Temmuz 2025<\/strong>: FDA onay haberiyle 65-68 $ aral\u0131\u011f\u0131na t\u0131rmand\u0131<br\/> <strong>A\u011fustos 2025<\/strong>: G\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131yla t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 73,47 $'a y\u00fckseldi<br\/> <strong>1 Eyl\u00fcl 2025<\/strong>: 73,85 $ seviyesinde i\u015flem g\u00f6rerek g\u00fc\u00e7l\u00fc ivmeyi koruyor<\/p> <p>Bu etkileyici y\u00fckseli\u015f \u00fc\u00e7 ana fakt\u00f6rle desteklendi:<\/p> <ol> <li><strong>Rekor Finansal Performans<\/strong>: 2. \u00e7eyrek geliri 20,4 milyon $ ile y\u0131ll\u0131k %14 art\u0131\u015f<\/li> <li><strong>FDA D\u00fczenleyici Ba\u015far\u0131<\/strong>: Yeni nesil MRidium\u00ae 3870 sistemi i\u00e7in 510(k) onay\u0131<\/li> <li><strong>Piyasa Hakimiyeti<\/strong>: MRI uyumlu inf\u00fczyon pompalar\u0131nda %62 pazar pay\u0131<\/li> <\/ol> <p>Hissenin teknik g\u00f6stergeleri y\u00fckseli\u015f sinyalleri veriyor; 22 Nisan 2025'te Alt\u0131n Y\u0131ld\u0131z Sinyali olu\u015ftu ve pivot dipten %25 kazan\u00e7 sa\u011fland\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3> <p>Analistler, 2026 i\u00e7in ortalama fiyat hedefi olarak <strong>74,33 $<\/strong> ile g\u00fc\u00e7l\u00fc iyimserliklerini koruyor; bu mevcut seviyelerden \u0131l\u0131ml\u0131 bir y\u00fckseli\u015fi temsil ediyor (<a href=\"https:\/\/www.tipranks.com\/stocks\/irmd\/forecast\/\">TipRanks Tahmini<\/a>). Y\u00fcksek tahmin 81,00 $, d\u00fc\u015f\u00fck tahmin ise 70,00 $ seviyesinde.<\/p> <p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 75-78 $ aral\u0131\u011f\u0131 (4. \u00e7eyrek performans\u0131 ve \u00fcr\u00fcn lansman\u0131na ba\u011fl\u0131)<br\/> <strong>2026 Projeksiyonu<\/strong>: 78-85 $ aral\u0131\u011f\u0131 (MRidium 3870'nin tam ticari da\u011f\u0131t\u0131m\u0131)<\/p> <h3>Orta ve Uzun Vadeli G\u00f6r\u00fcn\u00fcm<\/h3> <p><strong>2028 Tahmini<\/strong>: 85-95 $ aral\u0131\u011f\u0131 (pazar geni\u015flemesi ve uluslararas\u0131 b\u00fcy\u00fcme)<br\/> <strong>2030 Projeksiyonu<\/strong>: 100-110+ $ (sekt\u00f6r liderli\u011fi peki\u015ftirme ve yeni \u00fcr\u00fcn hatlar\u0131)<\/p> <p>Bu projeksiyonlar, \u015firketin b\u00fcy\u00fcme stratejisini s\u00fcrd\u00fcrmesi ve teknolojik rekabet avantaj\u0131n\u0131 korumas\u0131 varsay\u0131m\u0131yla yap\u0131lm\u0131\u015ft\u0131r.<\/p> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut seviyeler, son kazan\u00e7lara ra\u011fmen cazip giri\u015f noktalar\u0131 sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici Zorluklar<\/strong>: Medikal cihaz \u015firketleri i\u00e7in FDA uyum maliyetleri y\u0131ll\u0131k ortalama 31 milyon $ (<a href=\"https:\/\/dcfmodeling.com\/products\/irmd-swot-analysis\">SWOT Analizi<\/a>). Gelecekteki onaylarda ya\u015fanacak gecikmeler b\u00fcy\u00fcmeyi etkileyebilir.<\/li> <li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Medtronic (130 milyar $ piyasa de\u011feri) ve Philips Healthcare (25 milyar $ piyasa de\u011feri) gibi devlerle rekabet, rakip teknolojilerin geli\u015ftirilmesine yol a\u00e7abilir.<\/li> <li><strong>Geri \u00d6deme De\u011fi\u015fiklikleri<\/strong>: Medicare'de %4,5 ve \u00f6zel sigortalarda %2,8 kesintiler, hastanelerin sermaye harcamalar\u0131n\u0131 bask\u0131layabilir.<\/li> <li><strong>De\u011ferleme Endi\u015feleri<\/strong>: 25 kat kazan\u00e7 \u00e7arpanlar\u0131yla i\u015flem g\u00f6rmek, y\u00fcksek b\u00fcy\u00fcmenin devam\u0131n\u0131 gerektirir.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA Onay Ba\u015far\u0131s\u0131<\/strong>: MRidium\u00ae 3870, %12 daha y\u00fcksek fiyatland\u0131rma g\u00fcc\u00fcyle 510(k) onay\u0131 ald\u0131 (<a href=\"https:\/\/www.iradimed.com\/news\/iradimed-corporation-announces-fda-510k-clearance-for-mridium-3870-infusion-pump-system\">\u015eirket Duyurusu<\/a>)<\/li> <li><strong>Rekor Finansallar<\/strong>: 15 \u00e7eyrek \u00fcst \u00fcste rekor gelir ve %78 br\u00fct kar marj\u0131<\/li> <li><strong>Pazar Hakimiyeti<\/strong>: MRI inf\u00fczyon pompalar\u0131nda %62, genel \u00f6zel pazarda %55 pay<\/li> <li><strong>Stratejik Geni\u015fleme<\/strong>: 12,6 milyon $ de\u011ferinde Orlando \u00fcretim tesisi \u00fcretim kapasitesini art\u0131r\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ul> <li><strong>Stratejik Giri\u015f<\/strong>: Kazan\u00e7 volatilitesi etraf\u0131nda zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k 100-200 $ tutar\u0131nda dolar maliyeti ortalamas\u0131 yap\u0131n<\/li> <li><strong>Kazan\u00e7 Oyunu<\/strong>: 30 Ekim i\u00e7in fiyat uyar\u0131lar\u0131 kurun; kazan\u00e7 sonras\u0131 hisse %3-5 d\u00fc\u015ferse almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/strong>: Medikal cihaz sekt\u00f6r\u00fcndeki volatilite nedeniyle toplam portf\u00f6y\u00fcn %5-10'u ile s\u0131n\u0131rlay\u0131n<\/li> <li><strong>Esprili Bilgelik<\/strong>: \"IRMD ticareti yapmak MRI g\u00fcvenli\u011fi gibidir\u2014haz\u0131rl\u0131ks\u0131z acele ederseniz beklenmedik y\u00f6nlere \u00e7ekilebilirsiniz. Yava\u015f ve istikrarl\u0131 hizalanma en net sonu\u00e7lar\u0131 verir!\"<\/li> <\/ul> <h2>\u2705 IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Y\u00f6netilebilir miktarlarla ba\u015flay\u0131n\u2014k\u0131smi hisseler i\u00e7in 50 $ bile yeterlidir<\/td><\/tr> <tr><td>3<\/td><td>\"IRMD\" sembol\u00fc ile arama yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Sat\u0131n alma \u00f6ncesi t\u00fcm detaylar\u0131 ve \u00fccretleri kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Takip kurun<\/td><td>Kazan\u00e7 tarihleri ve \u00f6nemli destek seviyeleri i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td><\/tr> <tr><td>8<\/td><td>\u0130\u015flemleri belgeleyin<\/td><td>Vergi ve performans takibi i\u00e7in kay\u0131t tutun<\/td><\/tr> <tr><td>9<\/td><td>G\u00fcncel kal\u0131n<\/td><td>\u015eirket haberleri, FDA geli\u015fmeleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc trendlerini takip edin<\/td><\/tr> <tr><td>10<\/td><td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><td>Mali sonu\u00e7lara g\u00f6re yat\u0131r\u0131m tezini \u00e7eyrek d\u00f6nemlerde yeniden de\u011ferlendirin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 ola\u011fan\u00fcst\u00fc eri\u015filebilirlik \u00f6zellikleriyle basitle\u015ftirir:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci dakikalar i\u00e7inde tamamlan\u0131r<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>: Yeni ba\u015flayan t\u00fcccarlar i\u00e7in sezgisel aray\u00fcz<\/li> <li><strong>E\u011fitim kaynaklar\u0131<\/strong>: Pocket Option blogunda kapsaml\u0131 \u00f6\u011frenme materyalleri<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te IRADIMED: Medikal Teknoloji Yenilik\u00e7isi<\/h2> <p>IRADIMED CORPORATION, yakla\u015f\u0131k <strong>%55 pazar pay\u0131<\/strong> ile \u00f6zel MRI uyumlu medikal cihaz pazar\u0131nda liderdir (<a href=\"https:\/\/dcfmodeling.com\/products\/irmd-swot-analysis\">Piyasa Analizi<\/a>). D\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 tedarik\u00e7isi olarak benzersiz bir rekabet avantaj\u0131na sahiptir.<\/p> <p>Temel inf\u00fczyon sistemlerinin \u00f6tesinde, IRADIMED d\u00fcnyan\u0131n tek manyetik olmayan hasta monit\u00f6r\u00fc (3880 MRI Hasta Monit\u00f6r\u00fc) ve geli\u015fmi\u015f ferromanyetik alg\u0131lama sistemleri \u00fcretmektedir. Teknolojileri, geleneksel medikal ekipman\u0131n tehlikeli veya \u00e7al\u0131\u015fmaz hale geldi\u011fi 30.000 gauss manyetik alanlarda g\u00fcvenle \u00e7al\u0131\u015f\u0131r\u2014MRI ortamlar\u0131 i\u00e7in kritik bir gerekliliktir.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: IRADIMED, Forbes'un prestijli listesinde Amerika'n\u0131n en ba\u015far\u0131l\u0131 k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli \u015firketleri aras\u0131nda 24. s\u0131raya y\u00fckseldi; 2024'teki 59. s\u0131radan b\u00fcy\u00fck bir s\u0131\u00e7rama\u2014medikal teknolojideki ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme ve yeniliklerinin dikkat \u00e7ekici bir takdiri (<a href=\"https:\/\/www.biospace.com\/press-releases\/iradimed-corporation-on-forbes-list-of-americas-most-successful-small-cap-companies-for-2025\">Forbes Tan\u0131mas\u0131<\/a>).<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 IRADIMED Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla IRADIMED CORPORATION (IRMD), NASDAQ&#8217;ta <strong>73,85 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu, 2025 boyunca s\u00fcrekli rekor k\u0131ran \u00e7eyreklik sonu\u00e7lar sunan bir \u015firket i\u00e7in g\u00fc\u00e7l\u00fc bir ivmeyi temsil ediyor.<\/p>\n<p>Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik bir tarih. IRADIMED&#8217;in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirerek yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsatlar hem de riskler yaratm\u0131\u015ft\u0131r.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 IRMD Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>Son performans \u00f6r\u00fcnt\u00fclerine dayanarak, IRADIMED analist beklentilerini tutarl\u0131 \u015fekilde a\u015fm\u0131\u015ft\u0131r:<\/p>\n<ul>\n<li><strong>1 A\u011fustos 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: Tahminleri %13,95 a\u015farak 0,49 $ non-GAAP EPS bildirdi (<a href=\"https:\/\/public.com\/stocks\/irmd\/earnings\">Kazan\u00e7 Verileri<\/a>)<\/li>\n<li><strong>5 May\u0131s 2025 (1. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: Tahminleri %2,44 a\u015farak 0,42 $ non-GAAP EPS sundu<\/li>\n<li><strong>13 \u015eubat 2025 (2024 4. \u00c7eyrek)<\/strong>: Tam olarak beklentileri kar\u015f\u0131layarak 0,44 $ EPS<\/li>\n<li><strong>31 Ekim 2024 (2024 3. \u00c7eyrek)<\/strong>: Tahminleri %13,16 a\u015farak 0,43 $ EPS<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: IRADIMED beklentileri tutarl\u0131 \u015fekilde kar\u015f\u0131l\u0131yor veya a\u015f\u0131yor, son \u00e7eyreklerde \u00f6zellikle g\u00fc\u00e7l\u00fc bir performans sergiliyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>IRADIMED hisseleri son alt\u0131 ayda ola\u011fan\u00fcst\u00fc performans g\u00f6sterdi, May\u0131s&#8217;tan A\u011fustos 2025&#8217;e yakla\u015f\u0131k <strong>%40<\/strong> y\u00fckseldi:<\/p>\n<p><strong>Mart 2025<\/strong>: K\u0131\u015f konsolidasyonunun ard\u0131ndan 51-52 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<br \/> <strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u015fmas\u0131n\u0131n ard\u0131ndan 51,85 $ seviyesine ula\u015ft\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IRMD\/forecast\/\">Piyasa Analizi<\/a>)<br \/> <strong>Temmuz 2025<\/strong>: FDA onay haberiyle 65-68 $ aral\u0131\u011f\u0131na t\u0131rmand\u0131<br \/> <strong>A\u011fustos 2025<\/strong>: G\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131yla t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 73,47 $&#8217;a y\u00fckseldi<br \/> <strong>1 Eyl\u00fcl 2025<\/strong>: 73,85 $ seviyesinde i\u015flem g\u00f6rerek g\u00fc\u00e7l\u00fc ivmeyi koruyor<\/p>\n<p>Bu etkileyici y\u00fckseli\u015f \u00fc\u00e7 ana fakt\u00f6rle desteklendi:<\/p>\n<ol>\n<li><strong>Rekor Finansal Performans<\/strong>: 2. \u00e7eyrek geliri 20,4 milyon $ ile y\u0131ll\u0131k %14 art\u0131\u015f<\/li>\n<li><strong>FDA D\u00fczenleyici Ba\u015far\u0131<\/strong>: Yeni nesil MRidium\u00ae 3870 sistemi i\u00e7in 510(k) onay\u0131<\/li>\n<li><strong>Piyasa Hakimiyeti<\/strong>: MRI uyumlu inf\u00fczyon pompalar\u0131nda %62 pazar pay\u0131<\/li>\n<\/ol>\n<p>Hissenin teknik g\u00f6stergeleri y\u00fckseli\u015f sinyalleri veriyor; 22 Nisan 2025&#8217;te Alt\u0131n Y\u0131ld\u0131z Sinyali olu\u015ftu ve pivot dipten %25 kazan\u00e7 sa\u011fland\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3>\n<p>Analistler, 2026 i\u00e7in ortalama fiyat hedefi olarak <strong>74,33 $<\/strong> ile g\u00fc\u00e7l\u00fc iyimserliklerini koruyor; bu mevcut seviyelerden \u0131l\u0131ml\u0131 bir y\u00fckseli\u015fi temsil ediyor (<a href=\"https:\/\/www.tipranks.com\/stocks\/irmd\/forecast\/\">TipRanks Tahmini<\/a>). Y\u00fcksek tahmin 81,00 $, d\u00fc\u015f\u00fck tahmin ise 70,00 $ seviyesinde.<\/p>\n<p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 75-78 $ aral\u0131\u011f\u0131 (4. \u00e7eyrek performans\u0131 ve \u00fcr\u00fcn lansman\u0131na ba\u011fl\u0131)<br \/> <strong>2026 Projeksiyonu<\/strong>: 78-85 $ aral\u0131\u011f\u0131 (MRidium 3870&#8217;nin tam ticari da\u011f\u0131t\u0131m\u0131)<\/p>\n<h3>Orta ve Uzun Vadeli G\u00f6r\u00fcn\u00fcm<\/h3>\n<p><strong>2028 Tahmini<\/strong>: 85-95 $ aral\u0131\u011f\u0131 (pazar geni\u015flemesi ve uluslararas\u0131 b\u00fcy\u00fcme)<br \/> <strong>2030 Projeksiyonu<\/strong>: 100-110+ $ (sekt\u00f6r liderli\u011fi peki\u015ftirme ve yeni \u00fcr\u00fcn hatlar\u0131)<\/p>\n<p>Bu projeksiyonlar, \u015firketin b\u00fcy\u00fcme stratejisini s\u00fcrd\u00fcrmesi ve teknolojik rekabet avantaj\u0131n\u0131 korumas\u0131 varsay\u0131m\u0131yla yap\u0131lm\u0131\u015ft\u0131r.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut seviyeler, son kazan\u00e7lara ra\u011fmen cazip giri\u015f noktalar\u0131 sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici Zorluklar<\/strong>: Medikal cihaz \u015firketleri i\u00e7in FDA uyum maliyetleri y\u0131ll\u0131k ortalama 31 milyon $ (<a href=\"https:\/\/dcfmodeling.com\/products\/irmd-swot-analysis\">SWOT Analizi<\/a>). Gelecekteki onaylarda ya\u015fanacak gecikmeler b\u00fcy\u00fcmeyi etkileyebilir.<\/li>\n<li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Medtronic (130 milyar $ piyasa de\u011feri) ve Philips Healthcare (25 milyar $ piyasa de\u011feri) gibi devlerle rekabet, rakip teknolojilerin geli\u015ftirilmesine yol a\u00e7abilir.<\/li>\n<li><strong>Geri \u00d6deme De\u011fi\u015fiklikleri<\/strong>: Medicare&#8217;de %4,5 ve \u00f6zel sigortalarda %2,8 kesintiler, hastanelerin sermaye harcamalar\u0131n\u0131 bask\u0131layabilir.<\/li>\n<li><strong>De\u011ferleme Endi\u015feleri<\/strong>: 25 kat kazan\u00e7 \u00e7arpanlar\u0131yla i\u015flem g\u00f6rmek, y\u00fcksek b\u00fcy\u00fcmenin devam\u0131n\u0131 gerektirir.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA Onay Ba\u015far\u0131s\u0131<\/strong>: MRidium\u00ae 3870, %12 daha y\u00fcksek fiyatland\u0131rma g\u00fcc\u00fcyle 510(k) onay\u0131 ald\u0131 (<a href=\"https:\/\/www.iradimed.com\/news\/iradimed-corporation-announces-fda-510k-clearance-for-mridium-3870-infusion-pump-system\">\u015eirket Duyurusu<\/a>)<\/li>\n<li><strong>Rekor Finansallar<\/strong>: 15 \u00e7eyrek \u00fcst \u00fcste rekor gelir ve %78 br\u00fct kar marj\u0131<\/li>\n<li><strong>Pazar Hakimiyeti<\/strong>: MRI inf\u00fczyon pompalar\u0131nda %62, genel \u00f6zel pazarda %55 pay<\/li>\n<li><strong>Stratejik Geni\u015fleme<\/strong>: 12,6 milyon $ de\u011ferinde Orlando \u00fcretim tesisi \u00fcretim kapasitesini art\u0131r\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ul>\n<li><strong>Stratejik Giri\u015f<\/strong>: Kazan\u00e7 volatilitesi etraf\u0131nda zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k 100-200 $ tutar\u0131nda dolar maliyeti ortalamas\u0131 yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 Oyunu<\/strong>: 30 Ekim i\u00e7in fiyat uyar\u0131lar\u0131 kurun; kazan\u00e7 sonras\u0131 hisse %3-5 d\u00fc\u015ferse almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/strong>: Medikal cihaz sekt\u00f6r\u00fcndeki volatilite nedeniyle toplam portf\u00f6y\u00fcn %5-10&#8217;u ile s\u0131n\u0131rlay\u0131n<\/li>\n<li><strong>Esprili Bilgelik<\/strong>: &#8220;IRMD ticareti yapmak MRI g\u00fcvenli\u011fi gibidir\u2014haz\u0131rl\u0131ks\u0131z acele ederseniz beklenmedik y\u00f6nlere \u00e7ekilebilirsiniz. Yava\u015f ve istikrarl\u0131 hizalanma en net sonu\u00e7lar\u0131 verir!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Y\u00f6netilebilir miktarlarla ba\u015flay\u0131n\u2014k\u0131smi hisseler i\u00e7in 50 $ bile yeterlidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;IRMD&#8221; sembol\u00fc ile arama yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Sat\u0131n alma \u00f6ncesi t\u00fcm detaylar\u0131 ve \u00fccretleri kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Takip kurun<\/td>\n<td>Kazan\u00e7 tarihleri ve \u00f6nemli destek seviyeleri i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0130\u015flemleri belgeleyin<\/td>\n<td>Vergi ve performans takibi i\u00e7in kay\u0131t tutun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>G\u00fcncel kal\u0131n<\/td>\n<td>\u015eirket haberleri, FDA geli\u015fmeleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc trendlerini takip edin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>Mali sonu\u00e7lara g\u00f6re yat\u0131r\u0131m tezini \u00e7eyrek d\u00f6nemlerde yeniden de\u011ferlendirin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 ola\u011fan\u00fcst\u00fc eri\u015filebilirlik \u00f6zellikleriyle basitle\u015ftirir:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci dakikalar i\u00e7inde tamamlan\u0131r<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>: Yeni ba\u015flayan t\u00fcccarlar i\u00e7in sezgisel aray\u00fcz<\/li>\n<li><strong>E\u011fitim kaynaklar\u0131<\/strong>: Pocket Option blogunda kapsaml\u0131 \u00f6\u011frenme materyalleri<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te IRADIMED: Medikal Teknoloji Yenilik\u00e7isi<\/h2>\n<p>IRADIMED CORPORATION, yakla\u015f\u0131k <strong>%55 pazar pay\u0131<\/strong> ile \u00f6zel MRI uyumlu medikal cihaz pazar\u0131nda liderdir (<a href=\"https:\/\/dcfmodeling.com\/products\/irmd-swot-analysis\">Piyasa Analizi<\/a>). D\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 tedarik\u00e7isi olarak benzersiz bir rekabet avantaj\u0131na sahiptir.<\/p>\n<p>Temel inf\u00fczyon sistemlerinin \u00f6tesinde, IRADIMED d\u00fcnyan\u0131n tek manyetik olmayan hasta monit\u00f6r\u00fc (3880 MRI Hasta Monit\u00f6r\u00fc) ve geli\u015fmi\u015f ferromanyetik alg\u0131lama sistemleri \u00fcretmektedir. Teknolojileri, geleneksel medikal ekipman\u0131n tehlikeli veya \u00e7al\u0131\u015fmaz hale geldi\u011fi 30.000 gauss manyetik alanlarda g\u00fcvenle \u00e7al\u0131\u015f\u0131r\u2014MRI ortamlar\u0131 i\u00e7in kritik bir gerekliliktir.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: IRADIMED, Forbes&#8217;un prestijli listesinde Amerika&#8217;n\u0131n en ba\u015far\u0131l\u0131 k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli \u015firketleri aras\u0131nda 24. s\u0131raya y\u00fckseldi; 2024&#8217;teki 59. s\u0131radan b\u00fcy\u00fck bir s\u0131\u00e7rama\u2014medikal teknolojideki ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme ve yeniliklerinin dikkat \u00e7ekici bir takdiri (<a href=\"https:\/\/www.biospace.com\/press-releases\/iradimed-corporation-on-forbes-list-of-americas-most-successful-small-cap-companies-for-2025\">Forbes Tan\u0131mas\u0131<\/a>).<\/p>\n"},"faq":[{"question":"IRADIMED hisseleri nereden al\u0131nabilir?","answer":"IRADIMED hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden \"IRMD\" sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"IRADIMED hisselerinin 2025 sonu fiyat hedefi nedir?","answer":"Analistlerin 2025 y\u0131l sonu i\u00e7in fiyat hedefi 75-78 $ aral\u0131\u011f\u0131ndad\u0131r, bu \u015firketin 4. \u00e7eyrek performans\u0131 ve \u00fcr\u00fcn lansmanlar\u0131na ba\u011fl\u0131d\u0131r."},{"question":"IRADIMED'in rekabet avantaj\u0131 nedir?","answer":"IRADIMED, d\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 tedarik\u00e7isi olarak benzersiz bir konuma sahiptir ve MRI uyumlu medikal cihaz pazar\u0131nda %62 pazar pay\u0131 ile liderdir."},{"question":"IRADIMED hisseleri i\u00e7in temel riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA onay s\u00fcre\u00e7lerindeki gecikmeler, b\u00fcy\u00fck rakiplerin rekabeti, geri \u00f6deme politikalar\u0131ndaki de\u011fi\u015fiklikler ve y\u00fcksek de\u011ferleme \u00e7arpanlar\u0131 yer almaktad\u0131r."},{"question":"Yeni ba\u015flayanlar IRADIMED hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar, dolar maliyeti ortalamas\u0131 y\u00f6ntemiyle haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yapmal\u0131, kazan\u00e7 raporlar\u0131 \u00f6ncesi fiyat uyar\u0131lar\u0131 kurmal\u0131 ve portf\u00f6ylerinin %5-10'unu bu sekt\u00f6re ay\u0131rmal\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"IRADIMED hisseleri nereden al\u0131nabilir?","answer":"IRADIMED hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden \"IRMD\" sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"IRADIMED hisselerinin 2025 sonu fiyat hedefi nedir?","answer":"Analistlerin 2025 y\u0131l sonu i\u00e7in fiyat hedefi 75-78 $ aral\u0131\u011f\u0131ndad\u0131r, bu \u015firketin 4. \u00e7eyrek performans\u0131 ve \u00fcr\u00fcn lansmanlar\u0131na ba\u011fl\u0131d\u0131r."},{"question":"IRADIMED'in rekabet avantaj\u0131 nedir?","answer":"IRADIMED, d\u00fcnyan\u0131n tek manyetik olmayan MRI inf\u00fczyon pompas\u0131 tedarik\u00e7isi olarak benzersiz bir konuma sahiptir ve MRI uyumlu medikal cihaz pazar\u0131nda %62 pazar pay\u0131 ile liderdir."},{"question":"IRADIMED hisseleri i\u00e7in temel riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA onay s\u00fcre\u00e7lerindeki gecikmeler, b\u00fcy\u00fck rakiplerin rekabeti, geri \u00f6deme politikalar\u0131ndaki de\u011fi\u015fiklikler ve y\u00fcksek de\u011ferleme \u00e7arpanlar\u0131 yer almaktad\u0131r."},{"question":"Yeni ba\u015flayanlar IRADIMED hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar, dolar maliyeti ortalamas\u0131 y\u00f6ntemiyle haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yapmal\u0131, kazan\u00e7 raporlar\u0131 \u00f6ncesi fiyat uyar\u0131lar\u0131 kurmal\u0131 ve portf\u00f6ylerinin %5-10'unu bu sekt\u00f6re ay\u0131rmal\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T10:30:14+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T10:30:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\",\"name\":\"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-09-01T10:30:14+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T10:30:14+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T10:30:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/","name":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-09-01T10:30:14+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-iradimed-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"IRADIMED CORPORATION (IRMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IRADIMED CORPORATION (IRMD) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":366648,"slug":"how-to-buy-iradimed-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu IRADIMED CORPORATION (IRMD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu IRADIMED CORPORATION (IRMD)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-iradimed-corporation\/"},"pt_AA":{"locale":"pt_AA","id":366651,"slug":"how-to-buy-iradimed-corporation","post_title":"Como comprar a\u00e7\u00f5es da IRADIMED CORPORATION (IRMD) - Investimento em a\u00e7\u00f5es da IRADIMED CORPORATION (IRMD)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-iradimed-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/366650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=366650"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/366650\/revisions"}],"predecessor-version":[{"id":366654,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/366650\/revisions\/366654"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=366650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=366650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=366650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}